| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.14B | 138.58B | 92.15B | 86.42B | 79.29B | 79.54B |
| Gross Profit | 20.13B | 28.54B | 20.29B | 18.80B | 17.61B | 15.29B |
| EBITDA | 11.89B | 15.51B | 11.45B | 10.37B | 9.81B | 7.52B |
| Net Income | 5.21B | 7.13B | 5.46B | 4.81B | 4.56B | 3.07B |
Balance Sheet | ||||||
| Total Assets | 191.71B | 189.19B | 179.86B | 164.40B | 147.50B | 127.91B |
| Cash, Cash Equivalents and Short-Term Investments | 23.18B | 38.32B | 30.55B | 31.62B | 31.25B | 32.60B |
| Total Debt | 123.80B | 106.10B | 107.54B | 91.61B | 86.79B | 73.74B |
| Total Liabilities | 146.49B | 133.87B | 131.97B | 117.54B | 104.84B | 88.95B |
| Stockholders Equity | 39.43B | 53.04B | 42.14B | 38.80B | 34.79B | 31.26B |
Cash Flow | ||||||
| Free Cash Flow | 9.43B | 8.80B | -14.20B | -2.11B | -8.12B | 17.22B |
| Operating Cash Flow | 9.63B | 10.16B | -13.30B | 460.00M | -7.55B | 19.32B |
| Investing Cash Flow | 48.00M | 273.00M | -636.00M | -2.39B | -160.00M | -4.17B |
| Financing Cash Flow | -5.08B | -1.17B | 12.53B | 2.40B | 5.91B | -9.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | ¥11.84B | 170.52 | ― | 3.44% | ― | ― | |
62 Neutral | ¥48.40B | 6.44 | ― | 5.45% | 50.38% | 18.56% | |
62 Neutral | ¥14.40B | 15.76 | ― | 3.75% | 10.71% | -40.11% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥7.33B | 5.54 | ― | 3.58% | 10.95% | 105.00% | |
56 Neutral | ¥106.08B | -16.70 | ― | 5.49% | -9.75% | -30.70% | |
52 Neutral | ¥11.60B | 22.93 | ― | 4.61% | 2.52% | 455.59% |